Back to News
Market Impact: 0.2
Bioxytran Secures Attested Free Sale Certification for A-SUQAR®, Opening the Path to the UAE and Gulf Markets
Source: Nasdaq
Healthcare & BiotechRegulation & LegislationCompany Fundamentals
Bioxytran said its A-SUQAR® tablet received a government-issued Free Sale Certificate, legalized by the issuing country's Ministry of Foreign Affairs. The certificate has been prepared for attestation for use in the United Arab Emirates; the provided article text contains no further details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
More News
- Tech stocks are suffering their biggest selloff since Covid, as investors see premature end to AI datacenter boom
- Elon Musk's Tesla and SpaceX lose over $420 billion in combined market cap after midterms
- Qualcomm slides 9% after earnings, leading post-election chip stock sell-off
- South Korea’s KOSPI halts trade after 8% wipeout on AI losses
- U.S. stock futures rise after AI rout batters Wall St; payrolls data in focus
- ’Our phones are exploding’: Goldman Sachs dissects historic Wall Street crash